account_balanceBalance Sheet (BS) Summary

Updated: 03/31/20262026 Q1

Total Assets

109.8M USD

YoY +6.5%

Shareholders' Equity

68.6M USD

YoY +7.3%

Equity Ratio

62.4%

YoY +0.5pt

Book Value Per Share

2.89USD

YoY -81.7%

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityOtherNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2018

2019

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

98.05M

19.93M

0

78,000

118.81M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

1.48M

499,000

0

953,000

121.74M

2.93M

121.74M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

1.28M

316,000

0

6.52M

9.71M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

1.45M

1.13M

32.08M

-96.61M

33.21M

42.92M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

2,000

22.90M

238.81M

-160.00M

6,000

0

78.81M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Kalaris Therapeutics Inc

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data